Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06545305
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
None
First Post:
2024-08-01
Brief Title:
Incidence and Risk Factors of Ocular Complications Among Patients With Homocystinuria
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Incidence and Risk Factors of Ocular Complications Among Patients With Homocystinuria in Jeddah Saudi Arabia A Cross-sectional Study
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Background Cysteine beta-synthase CBS deficiency often known as classic homocystinuria HCU is an uncommon inborn mistake in methionine metabolism Developmental delay intellectual incapacity skeletal and vascular symptoms and ocular abnormalities are possible main clinical characteristics
Objective This study sought to describe the ocular anomalies that King Fahad Armed Forces Hospital Jeddah Saudi Arabia HCU patients presented with between 2018 and 2022
Objective This study sought to describe the ocular anomalies that King Fahad Armed Forces Hospital Jeddah Saudi Arabia HCU patients presented with between 2018 and 2022
Detailed Description:
This retrospective research included 6 HCU patients Demographic and clinical characteristics of patients as age gender comorbidities were collected Relevant clinical and ophthalmic assessments like visual acuity fundus examination findings complications and type of surgery were also reported
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None